Day: May 1, 2025

Lead Director Don Sturdivant Appointed Chairman of the Board, Jim Janik to Continue Serving as Director MILWAUKEE, Wis., May 01, 2025 (GLOBE NEWSWIRE) — Douglas Dynamics, Inc. (NYSE: PLOW), North America’s premier manufacturer and upfitter of work truck attachments and equipment, today announced a planned board leadership transition. Current Chairman of the Board, James (Jim) L. Janik, has decided to step down from his role as Chairman, effective April 30, 2025. Mr. Janik will continue to serve as a member of the Board of Directors, ensuring a smooth transition and continued strategic oversight. The Board of Directors has appointed Don Sturdivant, the current Lead Director, to succeed Mr. Janik as Chairman. “Jim has been a tremendous leader for Douglas Dynamics, guiding the Company through significant milestones for decades in...

Brera’s Strategy of Sustainable Growth and Local Engagement Reflects Evolving Industry Best Practices, Including Bottom-Up Value CreationWhile Hollywood stars Rob McElhenney (left) and Ryan Reynolds’ (right) club Wrexham was a U.K.mid-table 5th division team at the time of their acquisitionWhile Hollywood stars Rob McElhenney (left) and Ryan Reynolds’ (right) club Wrexham was a U.K.mid-table 5th division team at the time of their acquisition, Brera invested in Juve Stabia when it reached Serie B, the 2nd division of Italian football, after promotion from Serie CWhile Hollywood stars Rob McElhenney (left) and Ryan Reynolds’ (right) club Wrexham was a U.K.mid-table 5th division team at the time of their acquisition, Brera invested in Juve Stabia when it reached Serie B, the 2nd division of Italian football, after promotion from...

SOUTH SAN FRANCISCO, Calif., May 01, 2025 (GLOBE NEWSWIRE) — UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse diseases of aging, today announced that the Company will present 36-week data from the ASPIRE Phase 2B study at the Association for Research in Vision and Ophthalmology (ARVO) 2025 Annual Meeting being held on May 4-8, 2025 in Salt Lake City, Utah. ARVO 2025 Presentation Details: Title: Safety and Efficacy of Senolytic Candidate UBX1325 for Diabetic Macular Edema: The BEHOLD Phase 2 and ASPIRE Phase 2b TrialsPresentation Number: 4014 Session: Diabetic Macular Edema: Anti-VEGF Date & Time: Wednesday, May 7, 2025 at 11:00-11:15 a.m. MDT Location: Calvin L. Rampton Salt Palace Convention Center, Room 255ABCPresenter: Arshad M. Khanani, M.D., M.A.,...

SAN FRANCISCO and BOSTON, May 01, 2025 (GLOBE NEWSWIRE) — Apogee Therapeutics, Inc., (Nasdaq: APGE), today announced that members of management will present at the Bank of America Health Care Conference on Tuesday, May 13, 2025, at 1:40 p.m. P.T. / 4:40 p.m. E.T. A live and archived webcast of the presentation will be available via the News & Events page in the Investors section of the Apogee Therapeutics website. About Apogee Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, including for the treatment of AD, asthma, EoE, COPD and other I&I indications. Apogee’s antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating...

MORRISVILLE, N.C., May 01, 2025 (GLOBE NEWSWIRE) — Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, announced today that it will report its first quarter 2025 financial results on Thursday, May 8, 2025. The company will host a webcast at 8:30 a.m. Eastern Time to discuss its financial results and provide a corporate update. The webcast will be available on Liquidia’s website at https://liquidia.com/investors/events-and-presentations. A rebroadcast of the event will be available and archived for a period of one year at the same location. About Liquidia CorporationLiquidia Corporation is a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease. The company’s current focus spans the...

REDWOOD CITY, Calif., May 01, 2025 (GLOBE NEWSWIRE) — Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage rare disease company focused on significantly improving outcomes for individuals with hypoglycemia caused by hyperinsulinism, today announced that management will participate in the following investor conferences: Event: The Citizens JMP Life Sciences Conference Date: May 7-8, 2025 Event: H.C. Wainwright BioConnect Investor Conference Date: May 20, 2025 Event: Craig-Hallum Institutional Investor Conference Date: May 28, 2025 Event: Jefferies Global Healthcare Conference Date: June 3-5, 2025 Management will be participating in one-on-one investor meetings throughout the conferences. Investors interested in scheduling a meeting with the Rezolute management team should contact their JMP, H.C. Wainwright,...

SILVER SPRING, Md., May 01, 2025 (GLOBE NEWSWIRE) — Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix technologies, today announced that it will release its first quarter 2025 financial results after market close on Thursday, May 8, 2025. Members of the Company’s management team will host a conference call and webcast starting at 5:00 p.m. Eastern Time / 2:00 p.m. Pacific Time on the same day. The conference call can be accessed using the following information: Webcast: Click hereU.S. Investors: 877-407-8029International Investors: 201-689-8029Conference ID: 13753035 Please log in approximately 10 minutes prior to the scheduled start time. A live and archived webcast of the event will be available on the “Investors” section of the Elutia website at http://investors.elutia.com/. About ElutiaElutia...

SINGAPORE, May 01, 2025 (GLOBE NEWSWIRE) — Bitdeer Technologies Group (NASDAQ: BTDR) (“Bitdeer” or the “Company”), a world-leading technology company for Bitcoin mining, today announced that it has scheduled its first quarter 2025 earnings conference call and webcast for Thursday, May 15, 2025 at 8:00 AM EST. During the call, Bitdeer management will discuss the unaudited financial and operational results for the quarter ended March 31, 2025, followed by a question-and-answer session. Bitdeer will release the first quarter results before the call at approximately 7:00 AM EST on May 15, 2025. A copy of the earnings release will be available on the Company’s Investor Relations website at https://ir.bitdeer.com. Conference Call Information:Date: May 15, 2025 Time: 8:00 AM EST / 8:00 PM SGT Participant Call Links:Live Webcast: Link Participant...